文献速递瓣膜病与结构性心脏病心力衰竭与心肌病

循环miR-122-5p与TAVR术后左心室功能改善不佳相关并通过细胞外囊泡调控心肌细胞活力

Circulating MicroRNA-122-5p Is Associated With a Lack of Improvement in Left Ventricular Function After Transcatheter Aortic Valve Replacement and Regulates Viability of Cardiomyocytes Through Extracellular Vesicles.
PubMed 文献 · Circulation · 2022-07-08

本研究探讨经导管主动脉瓣置换术(TAVR)后循环细胞外囊泡(EV)中微小RNA(miRNA)的差异表达及其与左心室射血分数(LVEF)改善的关系。研究发现,主动脉瓣狭窄患者TAVR术后第7天多种EV相关miRNA显著失调,其中miR-122-5p水平较高与第7天及6个月LVEF改善呈负相关。机制上,miR-122-5p通过hnRNPU包裹入大EV从内皮细胞转运至心肌细胞,靶向抑制BCL2翻译而降低心肌细胞活力。

要点

  • TAVR术后循环EV中miR-122-5p水平较高与LVEF改善不佳独立相关。
  • miR-122-5p经大EV从内皮细胞转运至心肌细胞,抑制BCL2翻译促凋亡。
  • EV相关miR-122-5p或可作为TAVR术后心功能恢复的预测标志物。

核心结论

  • 循环中促凋亡的EV包裹的miR-122-5p水平升高与TAVR术后LVEF改善减少相关。
  • EV转运miR-122-5p以BCL2依赖方式调控心肌细胞活力和凋亡。

研究设计与样本

  • 研究采用无偏Taqman人类miRNA阵列检测TAVR患者循环EV相关miRNA的差异表达。
  • 利用患者来源样本和小鼠主动脉瓣狭窄模型进行验证。
  • 通过共培养实验、拷贝数分析、荧光显微镜、质谱、miRNA pulldown、电泳迁移率变动分析和RNA免疫沉淀探讨机制。

主要发现

  • TAVR术后第7天,主动脉瓣狭窄患者中7种EV miRNA(miR-122-5p、miR-26a、miR-192、miR-483-5p、miR-720、miR-885-5p和miR-1274)与术前相比显著失调。
  • miR-122-5p较高水平与TAVR术后第7天LVEF改善呈负相关(r=-0.264,P=0.015),与6个月LVEF改善也呈负相关(r=-0.328,P=0.0018)。
  • 小鼠实验显示miR-122-5p表达与心脏功能负相关,且与心肌细胞功能障碍相关。
  • miR-122-5p在内皮细胞中富集程度高于心肌细胞,可通过大EV从内皮细胞转运至心肌细胞。
  • 机制上,miR-122-5p以序列特异性方式与RNA结合蛋白hnRNPU相互作用而被包裹入大EV。

临床怎么用

  • 循环EV中miR-122-5p水平或可用于识别TAVR术后左心室功能改善不佳的高风险患者。
  • 针对miR-122-5p–hnRNPU–BCL2通路的干预可能为改善TAVR术后心肌恢复提供新策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transcatheter aortic valve replacement (TAVR) is a well-established treatment option for high- and intermediate-risk patients with severe symptomatic aortic valve stenosis. A majority of patients exhibit improvements in left ventricular ejection fraction (LVEF) after TAVR in response to TAVR-associated afterload reduction. However, a specific role for circulating microRNAs (miRNAs) in the improvement of cardiac function for patients after TAVR has not yet been investigated. Here, we profiled the differential expression of miRNAs in circulating extracellular vesicles (EVs) in patients after TAVR and, in particular, the novel role of circulating miR-122-5p in cardiomyocytes. METHODS: Circulating EV-associated miRNAs were investigated by use of an unbiased Taqman-based human miRNA array. Several EV miRNAs (miR-122-5p, miR-26a, miR-192, miR-483-5p, miR-720, miR-885-5p, and miR-1274) were significantly deregulated in patients with aortic valve stenosis at day 7 after TAVR compared with the preprocedural levels in patients without LVEF improvement. The higher levels of miR-122-5p were negatively correlated with LVEF improvement at both day 7 (r=-0.264 and P=0.015) and 6 months (r=-0.328 and P=0.0018) after TAVR. RESULTS: Using of patient-derived samples and a murine aortic valve stenosis model, we observed that the expression of miR-122-5p correlates negatively with cardiac function, which is associated with LVEF. Mice with graded wire injury-induced aortic valve stenosis demonstrated a higher level of miR-122-5p, which was related to cardiomyocyte dysfunction. Murine ex vivo experiments revealed that miR-122-5p is highly enriched in endothelial cells compared with cardiomyocytes. Coculture experiments, copy-number analysis, and fluorescence microscopy with Cy3-labeled miR-122-5p demonstrated that miR-122-5p can be shuttled through large EVs from endothelial cells into cardiomyocytes. Gain- and loss-of-function experiments suggested that EV-mediated shuttling of miR-122-5p increases the level of miR-122-5p in recipient cardiomyocytes. Mechanistically, mass spectrometry, miRNA pulldown, electrophoretic mobility shift assay, and RNA immunoprecipitation experiments confirmed that miR-122-5p interacts with the RNA-binding protein hnRNPU (heterogeneous nuclear ribonucleoprotein U) in a sequence-specific manner to encapsulate miR-122-5p into large EVs. On shuttling, miR-122-5p reduces the expression of the antiapoptotic gene BCL2 by binding to its 3' untranslated region to inhibit its translation, thereby decreasing the viability of target cardiomyocytes. CONCLUSIONS: Increased levels of circulating proapoptotic EV-incorporated miR-122-5p are associated with reduced LVEF after TAVR. EV shuttling of miR-122-5p regulates the viability and apoptosis of cardiomyocytes in a BCL2-dependent manner.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Hosen MR, Goody PR, Zietzer A, et al. Circulating MicroRNA-122-5p Is Associated With a Lack of Improvement in Left Ventricular Function After Transcatheter Aortic Valve Replacement and Regulates Viability of Cardiomyocytes Through Extracellular Vesicles. Circulation. 2022. PMID: 35862223. doi:10.1161/CIRCULATIONAHA.122.060258

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。